Impact Medical Solutions starts clinical trial and listing on Frankfurt Stock Exchange

Feb 25 2009

Impact Medical Solutions, Inc. has announced that it has commenced a pilot clinical study of the Company's proprietary information technology platform, Muscle Pattern Recognition (MPR).

MPR is a unique clinical tool that analyzes patterns of muscle recruitment and provides detailed physiological information on muscle function that can assist in the diagnosis and treatment of back and neck injuries and illness. The trial is being conducted at the Utah Spine and Joint Center in Salt Lake City, Utah and is expected to involve several hundred subjects.

"Back pain is one of the most common musculoskeletal problems in the world," said Wayne Cockburn, President and CEO at Impact Medical Solutions. "In North America, the annual direct and indirect cost of diagnosing and treating back injuries is estimated to be between $50-$100 billion. This pilot clinical trial is an important step in our development plans to make MPR widely available to those suffering from back pain. With the data we obtain from this study, we expect to start an independent clinical trial in the second half of 2009 which, if successful, will lead to the commercialization of the MPR System in North America, the European Union and other important markets." The Company stated that it plans on expanding the current trial over the coming months to include one or more centers in order to maximize subject enrollment.

The Company is also pleased to announce that its common shares have been accepted for trading on the Frankfurt Stock Exchange under the ticker symbol "0IM". The International Security Identification Number (ISIN) number is US45257K1007. The Frankfurt Stock Exchange (FWB) is one of the world's largest trading centers for securities. Operated by the Deutsche Boerse AG, FWB is the largest of all German stock exchanges and is responsible for approximately 90 percent of the securities trading volume in Germany. The Frankfurt Stock Exchange facilitates advanced electronic trading, settlement and information systems and enables cross-border trading for international investors.

"The listing of our shares on one of the world's premier stock markets will open further opportunities to expand our reach and grow our shareholder base worldwide, and will help us establish a presence in what could emerge as one of our most important commercial markets in the future," commented Mr. Cockburn.